---
figid: PMC6757184__bsr-39-bsr20192466-g1
figlink: /pmc/articles/PMC6757184/figure/F1/
number: F1
caption: 'There may be activation of glypican-3, NF-kB, GSK-3β, ERK1/2 and/or co-activator
  of β-catenin, i.e. FHL2. Activation of β-catenin signaling may induce different
  pathways to induce the development of hepatoblastoma including inhibition of TNF-α-dependent
  apoptosis, increase in the secretion of epithelial growth factor (EGF) and formation
  of complex of β-catenin with YAP-1 protein. This interaction may activate mTOR pathway
  to increase the expression of SLC38A1 (amino acid transporter) that may be critical
  in the development of hepatoblastoma. Abbreviations: mTOR, mammalian target of rapamycin;
  TNF-α, tumor necrosis factor-α.'
pmcid: PMC6757184
papertitle: Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
reftext: Ying-Li Sha, et al. Biosci Rep. 2019 Sep 30;39(9):BSR20192466.
pmc_ranked_result_index: '50922'
pathway_score: 0.9401131
filename: bsr-39-bsr20192466-g1.jpg
figtitle: Wnt/Beta-catenin signaling as a useful therapeutic target in hepatoblastoma
year: '2019'
organisms: Homo sapiens
ndex: 2c3e8e14-dec2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6757184__bsr-39-bsr20192466-g1.html
  '@type': Dataset
  description: 'There may be activation of glypican-3, NF-kB, GSK-3β, ERK1/2 and/or
    co-activator of β-catenin, i.e. FHL2. Activation of β-catenin signaling may induce
    different pathways to induce the development of hepatoblastoma including inhibition
    of TNF-α-dependent apoptosis, increase in the secretion of epithelial growth factor
    (EGF) and formation of complex of β-catenin with YAP-1 protein. This interaction
    may activate mTOR pathway to increase the expression of SLC38A1 (amino acid transporter)
    that may be critical in the development of hepatoblastoma. Abbreviations: mTOR,
    mammalian target of rapamycin; TNF-α, tumor necrosis factor-α.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - EGF
  - MAPK3
  - FHL2
  - GSK3B
  - NFKB1
  - MAPK1
  - TNF
  - SLC38A1
  - Hepatoblastoma
genes:
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: (CTNNB1)
  symbol: CTNNB1
  source: hgnc_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FHL2
  symbol: FHL2
  source: hgnc_symbol
  hgnc_symbol: FHL2
  entrez: '2274'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: SLC38A1
  symbol: SLC38A1
  source: hgnc_symbol
  hgnc_symbol: SLC38A1
  entrez: '81539'
chemicals: []
diseases:
- word: Hepatoblastoma
  source: MESH
  identifier: D018197
figid_alias: PMC6757184__F1
redirect_from: /figures/PMC6757184__F1
figtype: Figure
---
